Oracles, Two-Faced

Oracle's Two-Faced Market: Stock Rebounds While Credit Markets Flash Their Loudest Warning in 18 Years

Published on 07/31/2026 at 03:41 | Redaktion boerse-global.de

Oracle's stock rebounds on $638B AI backlog, but credit downgrade and record CDS spreads signal rising default risk.

Oracle Stock vs Bonds: AI Backlog Boom Masks Credit Downgrade Risk
Oracle's Two-Faced Market: Stock Rebounds While Credit Markets Flash Their Loudest Warning in 18 Years Illustration mit AI erstellt übermittelt durch boerse-global.de

The numbers don't lie, but they do contradict each other. Oracle shares have staged a sharp recovery off a 52-week low, yet the company's credit default swaps just hit their most expensive level since records began in late 2008. Both facts are true. Both happened within days of each other. And both are telling investors completely different stories about the same company.

A Bounce Built on a Backlog

The stock's latest surge came on Thursday, when Oracle jumped 6.21 percent to EUR 109.40. The trigger was a single figure: the company's remaining performance obligations — the value of contracted but not yet delivered services — have ballooned to $638 billion, a 363 percent increase year over year. Long-term agreements for AI model training and inference are driving the explosion, with enterprise clients booking compute capacity years in advance.

That Thursday gain followed a grim Tuesday, when the shares touched EUR 100.76, their lowest point in 52 weeks. The whiplash has been brutal: even after the rebound, Oracle sits roughly 61 percent below its September 2025 all-time high of EUR 280.70.

The backlog story has shifted the market's focus. After months of obsessing over the cost of Oracle's infrastructure buildout, investors are now weighing the revenue potential locked into those multi-year contracts. Analysts have begun describing the risk-reward profile as potentially asymmetric, arguing the current valuation may underestimate the long-term margin strength of the cloud infrastructure business. That framing tends to make short sellers nervous.

Should investors sell immediately? Or is it worth buying Oracle?

The Bond Market's Verdict

But while equity traders celebrated, the credit market delivered a far less forgiving assessment. On Monday, the cost of insuring Oracle's debt against default — measured through credit default swaps — climbed to roughly 2.03 percentage points annually, the highest reading since the data series began in 2008.

The catalyst was unambiguous. S&P Global Ratings downgraded Oracle's long-term issuer rating one notch from BBB to BBB-, and cut the short-term rating from A-2 to A-3. That leaves the company just one step above speculative grade. Moody's has additionally maintained a negative outlook, leaving the door open for further downgrades down the line.

The fundamentals behind that rating action are stark. Oracle generated negative free cash flow of $23.7 billion in fiscal 2026, while total debt sits at approximately $130 billion. The company poured $55.7 billion into building AI data centers — more than double the prior year's capex — a pace that has clearly outstripped its ability to self-fund.

A Concentration Risk That Compounds the Problem

Adding to the strain is a significant concentration risk: roughly half of Oracle's unfilled orders are tied to a single customer, OpenAI. One analyst at Sevens Report Research has warned that Oracle's financial strain could serve as the "canary in the coal mine" for the broader AI rally — an early warning that the market has yet to price in.

Management has pushed back on the narrative, pointing out that much of the new AI contract volume is prepaid or involves customers bringing their own hardware, which reduces Oracle's financial exposure. That argument appears to have resonated with equity buyers on Thursday, who chose to emphasize the long-term revenue potential over the near-term cash flow drain.

The Technical Picture Remains Fraught

The charts offer little comfort for bulls. The 14-day RSI sits at 39.6, having emerged from oversold territory without yet generating a clear buy signal. Oracle's stock remains nearly 30 percent below its 200-day moving average of EUR 156.23, and the 50-day average at EUR 143.67 is also a distant target. The shares would need to reclaim both levels to suggest anything resembling a sustainable trend reversal.

The company has lost more than 60 percent of its value since the September 2025 peak — a decline that goes well beyond a garden-variety correction. The recent bounce, while technically overdue after a 33.45 percent year-to-date slide, looks more like a pause in a downtrend than the beginning of a genuine turnaround.

Oracle at a turning point? This analysis reveals what investors need to know now.

A Tale of Two Markets

The tension is stark: a stock that jumps more than six percent while its own credit default swaps sit at an 18-year high is sending two irreconcilable signals. History suggests the credit market usually gets the final say.

Notably, neither Microsoft nor Amazon has faced a downgrade despite their own debt-fueled AI spending sprees. Oracle is hardly alone in this arms race for computing capacity, but it has become the most visible flashpoint for investor anxiety about how these expenditures will ultimately be financed.

The next test arrives with quarterly earnings, expected in mid-September. That's when the market will see whether Oracle can convert its record backlog into profitable growth — or whether the bond market's caution proves more prescient than the equity market's relief rally. For now, the stock's recovery rests almost entirely on faith that the order book will eventually translate into real cash flow. The credit market, for its part, is pricing in considerably more doubt.

Ad

Oracle Stock: New Analysis - 31 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLES | boerse | 69903009 |